South Korea
· Delayed Price · Currency is KRW High Tech Pharm Statistics
Total Valuation
High Tech Pharm has a market cap or net worth of KRW 145.04 billion. The enterprise value is 154.48 billion.
| Market Cap | 145.04B |
| Enterprise Value | 154.48B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
High Tech Pharm has 10.63 million shares outstanding. The number of shares has decreased by -33.55% in one year.
| Shares Outstanding | 10.63M |
| Shares Change (YoY) | -33.55% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 5.53% |
| Owned by Institutions (%) | 0.02% |
| Float | 5.84M |
Valuation Ratios
The trailing PE ratio is 7.14.
| PE Ratio | 7.14 |
| Forward PE | n/a |
| PS Ratio | 1.16 |
| PB Ratio | 1.27 |
| P/FCF Ratio | 47.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.15, with an EV/FCF ratio of 50.24.
| EV / Earnings | 11.42 |
| EV / Sales | 1.85 |
| EV / EBITDA | 7.15 |
| EV / EBIT | 9.36 |
| EV / FCF | 50.24 |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 14.91.
| Current Ratio | 2.87 |
| Quick Ratio | 1.29 |
| Debt / Equity | 14.91 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | 5.52 |
| Interest Coverage | 19.04 |
Financial Efficiency
Return on equity (ROE) is 12.54% and return on invested capital (ROIC) is 8.28%.
| Return on Equity (ROE) | 12.54% |
| Return on Assets (ROA) | 7.45% |
| Return on Capital (ROIC) | 8.28% |
| Revenue Per Employee | 1.28B |
| Profits Per Employee | 208.04M |
| Employee Count | 65 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 2.19 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.03% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +32.03% |
| 50-Day Moving Average | 16,531.20 |
| 200-Day Moving Average | 12,267.18 |
| Relative Strength Index (RSI) | 38.79 |
| Average Volume (20 Days) | 66,442 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, High Tech Pharm had revenue of KRW 83.50 billion and earned 13.52 billion in profits. Earnings per share was 1,910.97.
| Revenue | 83.50B |
| Gross Profit | 19.78B |
| Operating Income | 16.51B |
| Pretax Income | 16.73B |
| Net Income | 13.52B |
| EBITDA | 21.60B |
| EBIT | 16.51B |
| Earnings Per Share (EPS) | 1,910.97 |
Balance Sheet
The company has 7.54 billion in cash and 16.98 billion in debt, giving a net cash position of -9.45 billion or -888.38 per share.
| Cash & Cash Equivalents | 7.54B |
| Total Debt | 16.98B |
| Net Cash | -9.45B |
| Net Cash Per Share | -888.38 |
| Equity (Book Value) | 113.95B |
| Book Value Per Share | 10,710.12 |
| Working Capital | 42.43B |
Cash Flow
In the last 12 months, operating cash flow was 6.79 billion and capital expenditures -3.72 billion, giving a free cash flow of 3.08 billion.
| Operating Cash Flow | 6.79B |
| Capital Expenditures | -3.72B |
| Free Cash Flow | 3.08B |
| FCF Per Share | 289.21 |
Margins
Gross margin is 23.69%, with operating and profit margins of 19.78% and 16.19%.
| Gross Margin | 23.69% |
| Operating Margin | 19.78% |
| Pretax Margin | 20.03% |
| Profit Margin | 16.19% |
| EBITDA Margin | 25.86% |
| EBIT Margin | 19.78% |
| FCF Margin | 3.68% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 0.72%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 0.72% |
| Dividend Growth (YoY) | 114.29% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 5.24% |
| Buyback Yield | 33.55% |
| Shareholder Yield | 34.26% |
| Earnings Yield | 14.01% |
| FCF Yield | 2.12% |
Stock Splits
The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 27, 2023 |
| Split Type | Forward |
| Split Ratio | 1.5 |